CLINICAL_TRIALS
trial_result
· 2014-08-05
Clinical Trial Update: Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial comparing Teneligliptin (MP-513) to placebo in Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Handok Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED